GERMAN PHARMACEUTICAL COMPANIES CRITICISE WORKING PAPER ON HEALTH REFORM

Schwarz Pharma AG and Schering AG said the price limits will lead to less money to fund the research and development of new medicines. Sharewatch (http://www.sharewatch.com/story.php?storynumber=193400)